The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

TOP NEWS: AstraZeneca Boss Denounces "Me First" Approach To Covid Jabs

Mon, 25th Jan 2021 14:45

(Alliance News) - The boss of British-Swedish drugs giant AstraZeneca PLC, which with Oxford University has produced a Covid vaccine, denounced Monday a "me first" approach by some countries to obtaining doses.

AstraZeneca Chief Executive Pascal Soriot, speaking at a virtual event for the Davos World Economic Forum, also attacked a lack of global preparation for the deadly coronavirus pandemic.

The arrival of ground-breaking Covid-19 vaccines could have been grounds for celebrating, "but it unfortunately wasn't because there was a little bit of 'me first' behaviour", Soriot said.

"Globally, it is fair to say we could and should have been better prepared for this pandemic," he added.

Soriot noted however that "things are changing and international collaboration is emerging" over the coronavirus that has claimed the lives of more than two million people.

"There are many good examples of tremendous public-private collaboration actually in many countries," he said.

Going forward, "the first thing to do is to invest in prevention and early detection and early treatment," Soriot added.

He noted that among the world's most industrialised countries, only 3% of health expenditure is spent on prevention.

"Twenty percent of this 3.0%...is spent on immunisation and early detections of disease.

"So, essentially, we kind of tend to wait for people to become sick to try to address that, as opposed to early detecting (of) disease and preventing it."

source: AFP

Copyright 2021 Alliance News Limited. All Rights Reserved.

Related Shares

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsort...

3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out...

2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for pr...

2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood canc...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.